NDC Package 70409-2187-9 Abatacept

Injection, Powder, Lyophilized, For Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70409-2187-9
Package Description:
10.2 kg in 1 BOTTLE
Product Code:
Non-Proprietary Name:
Abatacept
Substance Name:
Abatacept
Usage Information:
This medication is used to treat rheumatoid arthritis, a condition in which the body's own defense system (immune system) attacks healthy tissue. This leads to swelling in the joints, which causes pain and makes it harder to move. Abatacept works by weakening your immune system. This effect helps to slow down joint damage and reduce joint pain and swelling so you can move better. This medication is also used to treat other types of arthritis (such as juvenile idiopathic arthritis, psoriatic arthritis).
11-Digit NDC Billing Format:
70409218709
Product Type:
Bulk Ingredient
Labeler Name:
Bristol-myers Squibb Company
Dosage Form:
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date:
12-19-2011
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70409-2187-9?

The NDC Packaged Code 70409-2187-9 is assigned to an UNFINISHED drug package of 10.2 kg in 1 bottle of Abatacept, a bulk ingredient labeled by Bristol-myers Squibb Company. The product's dosage form is injection, powder, lyophilized, for solution and is administered via form.

Is NDC 70409-2187 included in the NDC Directory?

Yes, Abatacept is an UNFINISHED PRODUCT with code 70409-2187 that is active and included in the NDC Directory. The product was first marketed by Bristol-myers Squibb Company on December 19, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70409-2187-9?

The 11-digit format is 70409218709. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170409-2187-95-4-270409-2187-09